Announcement of important resolutions of the
2022 Shareholders' Meeting
Date of events
2022/06/24
To which item it meets
paragraph 18
Statement
1.Date of the shareholders' meeting:2022/06/24
2.Important resolutions I.Profit distribution/deficit compensation:
Acknowledgment of the 2021 deficit compensation.
3.Important resolutions II.Amendments of the company charter:
Approved the amendment to the "Articles of Incorporation"
4.Important resolutions III.Business report and financial statements:
Acknowledgment of the company's 2021 Business Report and
Financial Statements.
5.Important resolutions IV.Election for directors and supervisors:None.
6.Important resolutions V.Other matters:
(1) Approved the 2022 conduct private placement of common shares
through cash capital increase.
(2) Approved the lifting of non-competition restrictions for directors.
(3) Approved the revision of "Operational procedures for Acquisition
and Disposal of Assets"
(4) Approved the Amendment to "Rules and Procedures of
Shareholders' Meeting".
7.Any other matters that need to be specified:None.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Raku Co. Ltd. published this content on 01 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 July 2022 08:42:10 UTC.
Raku Co Ltd, formerly Kino Biotech Co., Ltd., is a Singapore-based company. The Company is an integrated bio-nutraceutical and cosmeceutical company. The Company is focused on product conceptualization, development, commercialization, brand marketing, sale and distribution of healthcare and beauty products. The Company provides healthcare and beauty products and services through brands, including Kinohimitsu, Activa and Xpertise. It has over two logistic and distribution centers in Malaysia and China. The Company provides products to China, Singapore, Malaysia, Vietnam, Thailand and Indonesia.